The development of efficient delivery systems for nucleic acid-based cancer therapies is an ongoing challenge. Peptide-based systems are emerging as promising alternatives due to their tunable physiological properties. Nevertheless, their clinical translation is hindered by limited stability and susceptibility to proteolytic degradation. Here, we investigate D-peptides, protease-resistant synthetic peptides composed exclusively of D- amino acids (aa), as nanovectors for nucleic acid (NA) delivery. Due to their inverted chirality, Mirror- Image Peptides (MIPs) exhibit outstanding resistance to protease activity while retaining biological functionality. Among several candidates, we selected a 30-aa charged peptide sequence capable of self-assembling into nanostructures by complexing with negatively charged NAs. Using both manual and automated microfluidic-based synthesis, we generated nanoparticles complexed with either RNA or double-stranded DNA. Microfluidic synthesis provided superior size control compared to manual methods and, importantly, offers a scalable and reproducible platform suitable for future clinical translation. Stability and protease-resistance were assessed via gel electrophoresis, revealing significantly enhanced NA retention in MIP-based nanoparticles relative to their natural L-form counterparts. D-form nanoparticles were further evaluated in MDA-MB-231 luciferase-expressing cells, were they achieved siRNA-mediated gene silencing efficiencies comparable to L-form nanoparticles. The goal of this platform is to activate the cGAS-STING innate immune pathway by delivering dsDNA to the tumor microenvironment. This pathway is a central cytosolic DNA-sensing mechanism that triggers type I interferon production and a broad antitumor immune response. Preliminarily studies using a macrophage reporter cell lines (THP1-Dual™) confirmed robust pathway activation, supporting the underlying rationale. In parallel, epifluorescence imaging demonstrated efficient NP uptake in both cancer cells and immune cells, key players in orchestrating effective antitumor responses.

Banfi, A., Salvioni, L., Colombo, M., Prosperi, D. (2026). Harnessing Mirror-Image Peptides: Nanoparticle Vectors for Nucleic Acid Delivery. Intervento presentato a: BtBs day 2026, Milano, Italy.

Harnessing Mirror-Image Peptides: Nanoparticle Vectors for Nucleic Acid Delivery

Banfi, A
;
Salvioni, L;Colombo, M;Prosperi, D
2026

Abstract

The development of efficient delivery systems for nucleic acid-based cancer therapies is an ongoing challenge. Peptide-based systems are emerging as promising alternatives due to their tunable physiological properties. Nevertheless, their clinical translation is hindered by limited stability and susceptibility to proteolytic degradation. Here, we investigate D-peptides, protease-resistant synthetic peptides composed exclusively of D- amino acids (aa), as nanovectors for nucleic acid (NA) delivery. Due to their inverted chirality, Mirror- Image Peptides (MIPs) exhibit outstanding resistance to protease activity while retaining biological functionality. Among several candidates, we selected a 30-aa charged peptide sequence capable of self-assembling into nanostructures by complexing with negatively charged NAs. Using both manual and automated microfluidic-based synthesis, we generated nanoparticles complexed with either RNA or double-stranded DNA. Microfluidic synthesis provided superior size control compared to manual methods and, importantly, offers a scalable and reproducible platform suitable for future clinical translation. Stability and protease-resistance were assessed via gel electrophoresis, revealing significantly enhanced NA retention in MIP-based nanoparticles relative to their natural L-form counterparts. D-form nanoparticles were further evaluated in MDA-MB-231 luciferase-expressing cells, were they achieved siRNA-mediated gene silencing efficiencies comparable to L-form nanoparticles. The goal of this platform is to activate the cGAS-STING innate immune pathway by delivering dsDNA to the tumor microenvironment. This pathway is a central cytosolic DNA-sensing mechanism that triggers type I interferon production and a broad antitumor immune response. Preliminarily studies using a macrophage reporter cell lines (THP1-Dual™) confirmed robust pathway activation, supporting the underlying rationale. In parallel, epifluorescence imaging demonstrated efficient NP uptake in both cancer cells and immune cells, key players in orchestrating effective antitumor responses.
abstract + slide
peptide-based nanoparticles, targeted therapy, nucleic acids nanodelivery, immunotherapy, cancer
English
BtBs day 2026
2026
2026
none
Banfi, A., Salvioni, L., Colombo, M., Prosperi, D. (2026). Harnessing Mirror-Image Peptides: Nanoparticle Vectors for Nucleic Acid Delivery. Intervento presentato a: BtBs day 2026, Milano, Italy.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/593308
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact